Buprenorphine And Naloxone Film
Product Images NDC 67296-1933

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-1933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12mg-3mg-carton (12mg 3mg Carton)

The packaging label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg displays a yellow background with product name and strength prominently in the center. It specifies the form as sublingual film, includes warnings for pharmacist dispensing and child safety, and states the package contains 30 pouches, each with one film. The labeler is Alvogen, and dosage instructions and tamper-evident features are detailed on the box.*

FDA Label Image

12mg-3mg-pouch (12mg 3mg Pouch)

Label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg. The yellow label includes dosage form as sublingual film, a warning about accidental ingestion by children, storage instructions, and directions for use. Manufactured by Alvogen, the label also shows the NDC 47781-358-11 and a barcode.*

FDA Label Image

2mg-0pt5mg-carton (2mg 0pt5mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg, a human prescription drug film for buccal and sublingual administration. The label indicates the product contains 30 pouches, each with one sublingual film. The labeler is Alvogen, and it includes warnings and pharmacist instructions on a yellow background with red tamper-evident stripes.*

FDA Label Image

2mg-0pt5mg-pouch (2mg 0pt5mg Pouch)

Label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Redpharm Drug. The packaging is yellow with black text, showing the product name and strength prominently. It includes warnings for accidental ingestion, storage instructions, directions for use under the tongue or inside the cheek, and the manufacturer Alvogen. The label also features the NDC 47781-355-11 and a barcode.*

FDA Label Image

4mg-1mg-carton (4mg 1mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Redpharm Drug. The label indicates 30 pouches each containing one sublingual film, with instructions and warnings for safe use. The design features a yellow background with black and purple text, including a barcode and manufacturer details.*

FDA Label Image

4mg-1mg-pouch (4mg 1mg Pouch)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Alvogen. The label includes instructions for use, warnings about accidental ingestion by children, storage information, and dosing directions. The product is a single sublingual film intended for buccal or sublingual administration, with a barcode and NDC 47781-356-11 visible.*

FDA Label Image

8mg-2mg-carton (8mg 2mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Redpharm Drug (NDC 67296-1933). The label is primarily yellow with green and black text, indicating a box containing 30 pouches with one sublingual film each. Instructions emphasize pharmacist dispensing and child safety, and the product is for buccal/sublingual use.*

FDA Label Image

8mg-2mg-pouch (8mg 2mg Pouch)

The label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg features a bright yellow background with black text. It includes directions for use, storage instructions at 25°C with permitted excursions between 15°C to 30°C, warnings about accidental ingestion by children, and a note not to cut, chew or swallow the film. The product is labeled for sublingual administration, contains 1 film per package, and is manufactured by Alvogen under Rx only status. A barcode and the NDC 47781-357-11 are also shown.*

FDA Label Image

Figure-1 (Figure 1)

Illustration showing a hand using scissors to cut a strip of printed film, presumably demonstrating how to cut the Buprenorphine and Naloxone Sublingual Film into smaller pieces for dosing.*

FDA Label Image

Figure-2 (Figure 2)

An instructional illustration showing a sublingual film placed underneath the tongue inside an open mouth. The image demonstrates the correct buccal or sublingual administration route for the film dosage form.*

FDA Label Image

Figure-3 (Figure 3)

Instructional illustration showing a person placing a sublingual film under the tongue inside an open mouth, demonstrating the proper administration of Buprenorphine and Naloxone sublingual film.*

FDA Label Image

Structure-buprenorphine (Structure Buprenorphine)

Chemical structure of Buprenorphine Hydrochloride, showing its molecular framework including hydroxyl groups, methoxy group, cyclopropylmethyl substituent, and hydrochloride moiety.*

FDA Label Image

Structure-naloxone (Structure Naloxone)

Chemical structure of Buprenorphine showing its molecular arrangement, including the hydrogen chloride and water of crystallization indicated by HCl • 2H2O on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.